Biomanufacturing

JHS is Now the Largest Manufacturer in Spokane

Leading the Way in Biomanufacturing Innovation

Jubilant HollisterStier (JHS) is the largest manufacturer by number of employees in the Spokane area, according to the Spokane Journal of Business as of July 2025.

As local manufacturers, we produce life-saving medications and therapies that protect the health and safety of the people right here in Washington state and around the world. Innovation is at the heart of everything we do, and we take pride in addressing industry challenges head-on. By embracing the latest technology and seeking smarter, more efficient ways to work, we stay ahead in a quickly evolving industry.

“As Spokane’s leading manufacturer, we strive for excellence and innovation in the Inland Northwest, while also supporting the growing life science industry,” said Adam Snider, Director of Operations.

“This site reflects our community’s pride and resilience, serving as both a workplace and a home where generations have built their futures. We are dedicated to continuous growth, setting industry standards, and being a pillar of progress in our region.”

Our ongoing expansion project is set to double our manufacturing capacity with additional state-of-the-art production lines. The first new line opened in 2024, and the final phase of the project is on track to finish in 2026. By project completion, we will be able to serve over 300 million patients globally per year and will have added at least 400 new, high-quality jobs to the Spokane area.

A Culture of Excellence, Transparency, and Continuous Improvement

At a time of rapid growth, we are committed to building and maintaining our positive, transparent culture where we prioritize open communication and showing empathy to one another. JHS provides training to develop the abilities of our team members to maintain the level of manufacturing excellence and regulatory confidence our clients know to except. We encourage our team members to bring forth new ideas and solutions that drive continuous improvement and competitive advantage.

We’re still growing and adding new positions across multiple departments at both of our sites. Learn more about our open positions at https://www.jublhs.com/careers/

Related Posts

Exploring CMO Strategies with Chris Preti (DCAT Week)

Exploring CMO Strategies with Chris Preti (DCAT Week)

In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of discussion include operations and the strategic vision at Jubliant HollisterStier, the current...

Jubilant HollisterStier Appoints Chris Preti President

Jubilant HollisterStier Appoints Chris Preti President

On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of pharmaceutical industry experience and has been the recent president of HollisterStier Allergy....